TGFBI significantly influences tumor progression and dissemination in NSCLC (37) and is markedly overexpressed in various cancers, notably glioblastoma multiforme (GBM), where it is associated with poorer patient outcomes and increased chemotherapy resistance (38). The gene discussed is TGFBI; the disease is glioblastoma.